Related Experiment Video
Updated: Sep 12, 2025

A Rat Graft Rejection Model of Intestinal Transplantation with Exteriorized Ileostomy for Longitudinal Prognosis Assessment
Published on: June 10, 2025
IBD-linked Genetic Variance in Intestinal Transplantation: A Multicenter Cohort Analysis
Antoine Dubois1,2,3, Deborah S Jans4, Emilio Canovai1,5
1Leuven Intestinal Failure and Transplantation (LIFT), University Hospitals Leuven, Leuven, Belgium.
Genetic variations linked to inflammatory bowel disease (IBD) impact intestinal transplantation (ITx) outcomes. Identifying these IBD-associated genetic variants (IBDGVs) can improve donor selection and patient management in ITx.
Area of Science:
- Transplantation immunology
- Genetics
- Gastroenterology
Background:
- Intestinal transplantation (ITx) presents significant challenges in solid organ transplantation.
- Previous research indicated NOD2 genetic variations influence ITx outcomes.
- Numerous inflammatory bowel disease-associated genetic variants (IBDGVs) have since been identified.
Purpose of the Study:
- To investigate the prevalence of IBDGVs in European individuals undergoing ITx.
- To determine the association between IBDGVs and ITx outcomes, including patient and graft survival, and acute/chronic rejection.
- To explore the functional pathways implicated by these genetic associations.
Main Methods:
- A multicenter study involving 150 donor/recipient pairs from 5 international ITx centers.
- Genotyping-by-sequencing of 540 IBDGVs in a European cohort (53 donors, 101 recipients).
- Cox regression analysis for ITx outcomes (survival, rejection) and pathway analysis for significant IBDGVs.
Main Results:
- Multiple significant associations (P<0.05) were found between IBDGVs and ITx outcomes, affecting survival and rejection.
- Donor/recipient IBDGVs showed mixed protective and detrimental effects; combined donor-recipient IBDGVs were predominantly detrimental.
- Pathway analysis revealed enrichment in immune response and epithelial barrier function pathways, including IL-12 and S100 signaling.
Conclusions:
- The study identified several IBDGVs associated with ITx outcomes in a European cohort.
- These IBDGVs may serve as potential biomarkers for optimizing donor selection.
- Findings suggest IBDGVs could inform post-transplant management strategies to improve patient outcomes.
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Heritability
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:

